期刊文献+

HPLC测定HX0969w原料药的含量及有关物质 被引量:1

Determination of HX0969w and its related substances by HPLC
原文传递
导出
摘要 目的测定HX0969w原料药的含量及有关物质。方法采用线性梯度洗脱法,色谱柱为Agilent Zorbax XDB C18柱(150 mm×4.6 mm,5μm),流动相A为0.5%的碳酸氢铵,流动相B为乙腈,流速1 mL.min-1,检测波长260 nm。结果HX0969w和丙泊酚的线性范围分别为:1227.0~19.2μg.mL-1(r=0.9999)、97.7~3.1μg.mL-1(r=0.9998);日内RSD分别为0.17%、0.20%;日间RSD分别为0.33%、0.42%。结论所用方法简便、准确,适用于HX0969w原料药的含量测定及有关物质的检查。 OBJECTIVE To establish a method to determine the content of HX0969w and its related substances.METHODS Linear gradient elution was adopted with Agilent Zorbax XDB C18 column(150 mm×4.6 mm,5 μm),UV detection at 260 nm,and the mobile phase consisted of 0.5% ammonium bicarbonate-acetonitrile.The flow rate was 1.0 mL·min^-1.RESULTS The calibration curve of HX0969w was linear within the range of 1227.0-19.2 μg·mL-1(r=0.9999).The calibration curve of propofol was linear within the range of 97.7-3.1 μg·mL-1(r=0.9998).The Intra-day precision for this analysis of HX0969w and propofol were 0.17% and 0.20% respectively.The Inter-day precision of HX0969w and propofol were 0.33% and 0.42%,respectively.CONCLUSION The method is simple,accurate and effective for the quality control of HX0969w and its related substances.
出处 《华西药学杂志》 CAS CSCD 北大核心 2013年第3期300-302,共3页 West China Journal of Pharmaceutical Sciences
关键词 HX0969w 梯度洗脱 含量测定 有关物质 HX0969w Gradient elution Determination of content Related substances
  • 相关文献

参考文献5

  • 1Scott RP,Saunders DA, Norman J. Propofol. Clinical strategies for preventing the pain of injection [ J ]. Anaesthesia, 1988,43 ( 6 ) : 492 - 494.
  • 2Tan CH, Onsiong MK. Pain on injection of propofol [ J]. Anaesthesia, 1998,53 ( 5 ) :468 - 476.
  • 3Baker MT, Naguib M. Propofol: The challenges of formulation [ J ]. Anesthesiology,2005,103 (4) : 860 - 876.
  • 4王瑜,殷望,张文胜,杨俊,康仪.HPLC同时测定兔血浆中的丙泊酚及其前药HX0969w[J].华西药学杂志,2011,26(5):490-492. 被引量:3
  • 5Wang Yin, Yu Wang, Jun Yang,et al. Determination of HX0969w in rabbit whole blood by liquid chromatography - tandem mass specrtrometry and its application in a pharmacokinetics study[ J ]. Eur J mass spectromrtry,2011,17:405 - 413.

二级参考文献5

  • 1Scott RP, Saunders DA, Norman J. Propofol: clinical strategies for preventing the pain of injection [ J ]. Anaesthesia, 1988,43 ( 6 ) : 492 - 494.
  • 2Tan CH,Onsiong MK. Pain on injection of Propofol [J]. Anaesthesia, 1998,53 ( 5 ) :468 - 476.
  • 3Baker MT, Naguib M. Propofol: the challenges of formulation [J]. Anesthesiology, 2005,103 ( 4 ) : 860 - 876.
  • 4Wolf A, Weir P, Segar P, et al. hnpaired fatty acid oxidation in Propofol infusion syndrome [ J ]. Lancet,2001,357 ( 9256 ) :606 - 607.
  • 5Parke TJ,Stevens JE, Rice AS,et al. Metabolic acidosis and fatal myocardial failure after Propofol infusion in children :five case reports [ J ]. British Med J, 1992,305 ( 6854 ) :613 - 616.

共引文献2

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部